We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+12.42%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.38B
AUM Growth
+$114M
Cap. Flow
+$3.02M
Cap. Flow %
0.22%
Top 10 Hldgs %
24.18%
Holding
246
New
17
Increased
99
Reduced
75
Closed
49

Top Buys

Rank Stock Value
1
AZTA icon
Azenta
AZTA
+$15M
2
MDCO
Medicines Co
MDCO
+$13.1M
3
OKTA icon
Okta
OKTA
+$12.6M
4
CSOD
Cornerstone OnDemand, Inc.
CSOD
+$11.2M
5
VCTR icon
Victory Capital Holdings
VCTR
+$10.4M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$18.3M
2
RAMP icon
LiveRamp
RAMP
+$16.4M
3
TWOU
2U Inc
TWOU
+$11.5M
4
BFAM icon
Bright Horizons
BFAM
+$10.3M
5
NKTR icon
Nektar Therapeutics
NKTR
+$9.35M

Sector Composition

Rank Sector Weight
1 Technology 32.71%
2 Healthcare 18.29%
3 Industrials 15.25%
4 Consumer Discretionary 8.62%
5 Consumer Staples 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VST icon
176
Vistra
VST
$48.4B
$986K 0.07%
47,314
+2,495
+6% +$48.2K
P
177
DELISTED
Pandora Media Inc
P
$791K 0.06%
157,300
+12,500
+9% +$59.7K
MGM icon
178
MGM Resorts International
MGM
$11B
$775K 0.06%
22,119
-5,667
-20% -$199K
FLGT icon
179
Fulgent Genetics
FLGT
$524M
$772K 0.06%
193,004
-71,617
-27% -$315K
MTCH icon
180
Match Group
MTCH
$8.46B
$608K 0.04%
13,671
-15,365
-53% -$594K
FENC icon
181
Fennec Pharmaceuticals
FENC
$383M
$573K 0.04%
47,376
-11,668
-20% -$110K
NMRK icon
182
Newmark Group
NMRK
$2.55B
$567K 0.04%
37,344
-1,656
-4% -$25.6K
IOTS
183
DELISTED
Adesto Technologies Corp
IOTS
$554K 0.04%
+74,867
New +$507K
TRVG
184
trivago
TRVG
$383M
$526K 0.04%
15,144
-44,347
-75% -$1.75M
RCL icon
185
Royal Caribbean
RCL
$82.7B
$519K 0.04%
4,407
-2,545
-37% -$322K
LRMR icon
186
Larimar Therapeutics
LRMR
$437M
$448K 0.03%
+5,012
New +$425K
AVEO
187
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$448K 0.03%
15,438
+1,747
+13% +$51.1K
MARK
188
DELISTED
Remark Holdings, Inc.
MARK
$442K 0.03%
7,779
+6,141
+375% +$568K
FBRX icon
189
Forte Biosciences
FBRX
$1.57B
$434K 0.03%
98
+2
+2% +$9.26K
VYNT
190
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$389K 0.03%
1,570
-126
-7% -$35.5K
CSTE icon
191
Caesarstone
CSTE
$87.1M
$374K 0.03%
+19,031
New +$410K
KA
192
DELISTED
Kineta, Inc. Common Stock
KA
$335K 0.02%
+504
New +$304K
VSTM icon
193
Verastem
VSTM
$605M
$334K 0.02%
9,352
+1,053
+13% +$40.8K
A icon
194
Agilent Technologies
A
$41.9B
$258K 0.02%
3,856
+551
+17% +$38.6K
STLD icon
195
Steel Dynamics
STLD
$38B
$258K 0.02%
+5,841
New +$269K
APOG icon
196
Apogee Enterprises
APOG
$883M
$202K 0.01%
4,652
-32,374
-87% -$1.45M
SHSP
197
DELISTED
SharpSpring, Inc.
SHSP
$167K 0.01%
26,204
-27,196
-51% -$134K
APPN icon
198
Appian
APPN
$2.5B
– –
-34,875
Closed -$1.1M
ASML icon
199
ASML
ASML
$673B
– –
-1,397
Closed -$243K
AVNT icon
200
Avient
AVNT
$4.18B
– –
-5,248
Closed -$228K
6 7
8
9 10

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Granahan Investment Management held 246 positions worth $1.38B, up 8.9% from $1.27B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Granahan Investment Management's Q1 2018 filing shows 17 new, 99 increased, 75 reduced and 49 closed positions. Its largest new stake was Cornerstone OnDemand, Inc.: 275,122 shares worth $10.8M. The largest sale was Abiomed Inc, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Industrials.

  • Granahan Investment Management's largest Q1 2018 buy was Cornerstone OnDemand, Inc.: 275,122 shares worth $10.8M.
  • Granahan Investment Management added most to Azenta in Q1 2018, an estimated $15M increase.
  • Granahan Investment Management's biggest Q1 2018 reduction was Abiomed Inc, cutting an estimated $18.3M.
  • Granahan Investment Management fully exited LiveRamp in Q1 2018, selling an estimated $16.4M.
  • Granahan Investment Management's ten largest holdings make up 24% of its $1.38B portfolio in Q1 2018.
  • Granahan Investment Management opened 17 new positions and closed 49 in Q1 2018.
  • Granahan Investment Management's portfolio value rose 8.9% quarter-over-quarter to $1.38B.

Based on Granahan Investment Management's 13F filing for Q1 2018, filed 14 May 2018.